SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 26 of 37
Health
AstraZeneca says its Covid-19 vaccine is up to 90% effective
By
Jeremy Kahn
November 23, 2020
Newsletters
The great disconnect: Big cash is surging into the markets, and yet COVID is socking stocks
By
Bernhard Warner
November 20, 2020
Newsletters
The vaccine rally is on pause, even slowing Bitcoin’s march
By
Bernhard Warner
November 19, 2020
Health
Pfizer, BioNTech plan filing as COVID trials show their vaccine is 95% effective
By
Robert Langreth
and
Bloomberg
November 18, 2020
Newsletters
Here are the most bullish trades for 2021—and, no, Bitcoin does not top the list
By
Bernhard Warner
November 18, 2020
Airlines saw an immediate boost in passenger bookings following vaccine announcements
By
David Meyer
November 17, 2020
Finance
Warren Buffett is going all in on the vaccine rally, piling into these stocks
By
Katherine Chiglinsky
and
Bloomberg
November 17, 2020
Newsletters
Vaccine breakthroughs are unleashing a ‘value rally.’ Here’s what investors should know
By
Bernhard Warner
November 17, 2020
Health
Moderna says its COVID-19 vaccine is 94.5% effective
By
Robert Langreth
and
Bloomberg
November 16, 2020
Health
Moderna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s
By
Robert Langreth
and
Bloomberg
November 12, 2020
Newsletters
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
By
Bernhard Warner
November 12, 2020
Health
Cold storage requirements will create a vast logistical nightmare for distributing COVID-19 vaccine
By
Bloomberg
November 11, 2020
Health
Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
By
Riley Griffin
and
Bloomberg
November 10, 2020
Health
Creating a COVID vaccine is only half the battle
By
Sy Mukherjee
November 9, 2020
Finance
J.P. Morgan analysts call these 25 stocks ‘short’ candidates as a COVID vaccine gets closer
By
Lee Clifford
November 9, 2020
Most Popular
Success
Zoom’s CEO agrees with Bill Gates, Jensen Huang, and Jamie Dimon: A 3-day workweek is coming soon thanks to AI
By
Emma Burleigh
Personal Finance
Milestones like marriage and parenthood are so delayed for millennials and Gen Z many of them are skipping out on life...
By
Sydney Lake
Success
Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
By
Nick Lichtenberg